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Purpose: A carotid endarterectomy critical pathway (CP) targeting a 3-day postoperative 
course was introduced in March 1994. This retrospective analysis assesses its impact on 
operative results, postoperative length of stay (POD), and cost of hospitalization (COH). 
Methods: One hundred eighty-six patients who underwent 201 carotid endarterectomy 
procedures from Nov. 1992 to Feb. 1994 (Pre-CP; n = 67) and from Apr. 1994 to Jul. 
1995 (Post-CP; n = 134) at Johns Hopkins Hospital, a tertiary care referral center, were 
evaluated. 
Results: The Pre-CP and Post-CP groups had similar risk factors, postoperative morbid- 
ity rates, and mortality rates. Furthermore, they had similar mean POD (Pre-CP, 6.0 - 
0.5 days; Post-CP, 5.7 - 0.6 days; p = 0.79) and COH. However, only 85 of the Post-CP 
(63%) patients were actually placed on the CP (CP-starters); the mean POD was 3.4 + 
0.3 days among these CP-starters (p < 0.0001) and 2.8 -+ 0.1 days among the 74 
Post-CP patients (55%) that remained on the pathway (CP-finishers; p < 0.0001). The 
mean COH was reduced from $12,881 (Pre-CP) to $9701 for the CP-starters (p = 0.01) 
and to $8572 for the CP-finishers (p = 0.0001). However, we found that only 47 of the 
Pre-CP patients (70%) would have been eligible for the CP, and the mean POD among 
those cases was 4.2 - 0.4 days, which was not different han the mean POD among the 
CP-starters (p = 0.17). The mean COH of the eligible Pre-CP cases, $9508, was not 
significantly different from the COH of the CP-starters (p = 0.97). 
Conclusions: This subset analysis emphasizes the importance of establishing an accurate 
"control" group when studying a CP, because using all of the Pre-CP cases as the 
"control" group in the original analysis, including patients who would not have been 
candidates for the CP, clearly overstated the beneficial impact of the CP. (J Vasc Surg 
1997;26:186-92.) 
Controlling the costs of providing quality health 
care to our citizens is one of the most challenging 
issues in the United States today. On a per-capita 
basis, health care spending has increased from $200 
in 1960 to $2400 in 1990, and currently approxi- 
mately two thirds of these resources are paid to 
hospitals and physicians) It is not surprising, there- 
fore, that surgeons are especially motivated to be- 
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come more cost-effective in the treatment of their 
patients. Because the length of stay is clearly recog- 
nized to be a significant component of health care 
costs in the surgical patient population, 2 3 strategies 
have been developed specifically to reduce the dura- 
tion of hospitalization of surgical patients. One such 
strategy is the institution ofcritica! pathways (CP) to 
consolidate and standardize postoperative care in an 
attempt to maintain the quality of care while control- 
ling or reducing the costs of that care. 4 
Carotid endarterectomy (CEA) is the most fre- 
quently performed peripheral vascular operation in 
this country, currently accounting for over $1.2 bil- 
lion in annual health care expenditures, ~ and is there- 
fore an attractive target for cost-containment i itia- 
tives. At the Johns Hoplrdns Hospital, for example, it
is the most frequently performed operation on the 
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vascular surgical service. In March 1994 a CP was 
introduced to guide the management of patients 
who undergo CEA on this service. This report will 
analyze the initial impact of that CP on the results of 
CEA and will illustrate how the method of data 
analysis in this area may influence the implications of 
such an analysis. 
PATIENTS AND METHODS 
In March 1994 a CP was implemented for pa- 
tients undergoing CEA on the vascular surgery ser- 
vice at the Johns Hopkins Hospital. This pathway 
targeted a 3-day postoperative l ngth of stay (POD) 
and encouraged a 2-day POD. Patients were moni- 
tored in the intensive care unit (ICU) until the first 
postoperative morning. A preoperative angiogram 
on the day of admission, with a subsequent overnight 
stay, was allowed. Any patient was eligible for place- 
ment on the CP if electively admitted for CEA; 
patients were not excluded from CP management on
the basis of any comorbid medical diagnosis. Patients 
were excluded if they were electively admitted for a 
combined or staged additional surgical, usually car- 
diac, procedure; if they were transferred from an- 
other hospital or service for the CEA; or if the CEA 
was performed emergently. 
We reviewed the medical records of all patients 
who underwent CEA at the Johns Hopkins Hospital 
during the initial 16 months after the institution of 
the CP (Post-CP) and compared them with the 
records of all patients who underwent CEA during 
the 16 months before the institution of the CP (Pre- 
CP). Procedures performed during March 1994 
were excluded from the analysis to eliminate bias 
during implementation f the CP. 
From November 1992 to July 1995 (excluding 
March 1994), 237 CEA procedures were performed 
at the Johns Hopkins Hospital by the vascular sur- 
gery, neurosurgery, and general surgery services. The 
201 procedures (85%) performed by the three at- 
tending surgeons on the vascular surgery service 
form the basis of this study. The list of CEA cases was 
maintained prospectively by the attending surgeons; 
this list was confirmed to be complete by comparison 
with the hospital computerized medical records. 
The two groups were analyzed with respect o 
demographic variables and associated comorbidity, 
as well as clinical and angiographic indications for 
surgery. Outcome data studied included periopera- 
tive mortality data, stroke, and other major compli- 
cations, as well as hospital length of stay (LOS), 
charges, and readmission rates. 
Discrete variables were analyzed with X 2 analysis. 
All other data were analyzed with analysis of variance 
(ANOVA) using Schefffi's post hoc test (Statview 
4.53, Abacus Concepts, Berkeley, Calif.). All com- 
parisons were two-tailed, with statistical significance 
determined as a p value less than 0.05. 
RESULTS 
A total of 201 CEAs were performed on 186 
patients, including 67 Pre-CP and 134 Post-CP pro- 
cedures. As noted in Table I, the two groups were 
evenly matched with respect o demographic vari- 
ables. Hypertension and smoking were prevalent in 
both groups. Although there was no difference in the 
incidence of coronary artery disease between the two 
groups, a history of congestive heart failure and 
chronic obstructive pulmonary disease (COPD) oc- 
curred more often in the Pre-CP cases, whereas the 
Post-CP cases were somewhat older (Table I). The 
demographic variables were also similar in the con- 
trol and CP-starters ubgroups (see below), except 
that there was no statistical difference in the rate of 
COPD between these two subgroups (data not 
shown). 
The indications for operation are listed in Table I. 
CEA was performed more frequently for asymptom- 
atic disease during the Post-CP period. Angiograms 
were obtained in 198 of the 201 cases (99%), and 
complete records were available for review in 186 
cases (93%). The angiographic ndications for opera- 
tion were similar for the Pre-CP and Post-CP cases 
(Table I). The CEA was a reoperative procedure in 
1.5% of the Pre-CP group and 2.2% of the Post-CP 
group (p = 0.86, X 2 analysis). All operations were 
performed with the patient under general anesthesia. 
The mean total operating room tune was 123 -+ 5 
minutes for the Pre-CP group and 117 -+ 23 minutes 
in the Post-CP group (p = 0.26, ANOVA). 
There was one operative death (0.5%) and seven 
perioperative strokes (3.4%). As noted in Table II, 
there were no differences in the rates of operative 
death, perioperative stroke, or other major complica- 
tions between the two groups. Most significantly, the 
rate of readmission to the hospital within 30 days of 
operation was actually lower in the Post-CP group 
(Table II). 
The LOS, including preoperative, postoperative, 
and ICU days, were shorter in the Post-CP period 
when compared with the Pre-CP period, although 
these differences were not statistically significant (Ta- 
ble III). Although the overall charges, and subgroup 
analysis of these hospital charges, increased in the 
Post-CP period, these differences were not statisti- 
cally significant (Table III). 
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Table  I. Clinical characteristics and angiographic findings of Pre-CP and Post-CP groups 
Factor Pre-CP (%) Post-CP (%) p 
Number of patients 67 
Age (yr) 70.1 ± 
Male 39 
Hypertension 54 
Diabetes 20 
Hyperlipidemia 31 
Smoking history 58 
Coronary artery disease 49 
Prior myocardial infarction 29 
History of angina 39 
Congestive heart failure 18 
Prior coronary bypass 11 
Chronic obstructive pulmonary 15 
disease 
Symptom: 
Stroke 
TIA 
Amaurosis fugax 
Nonhemispheric 
Asymptomatic 
Angiogram: 
Preadmission 
Same day admit 
Stenosis (%) 87 -+ 1.9 
Ulcerated 
134 
1.0 72.3 ± 0.7 0.058* 
58 87 65 0.44 
82 117 87 0.41 
30 35 26 0.65 
47 64 48 0.96 
88 108 81 0.28 
73 81 60 0.11 
44 47 35 0.29 
59 67 50 0.29 
27 20 15 0.057* 
17 30 22 0.45 
23 15 11 0.053* 
7 10 18 13 0.71 
30 45 39 29 0.04* 
14 21 15 11 0.10 
5 7 7 5 0.75 
11 17 55 41 0.0008* 
49 45 0.67 
50 44 0.56 
88 ± 0.8 0.61 
56 67 0.24 
Age is mean ± standard error of the mean. pvalue for age and percent stenosis given by ANOVA. 
Coronary artery disease isdefined as history of myocardial infarct, angina, congestive h art failure, or coronary bypass surgery. 
*Significant p value. 
Tab le  I I .  Results 
Result Pre-CP (%) Post-CP (%) p 
n 67 134 
Death 1 1.5% 0 0.0% 0.72 
MI 2 3.0% 3 2.2% 0.89 
Stroke 2 3.0% 5 3.7% 0.88 
TIA 1 1.5% 1 0.8% 0.81 
Nonhemispheric symptoms 1 1.5% 1 0.8% 0.81 
Cranial nerve deficit 1 1.5% 3 2.2% 0.85 
Reexploration 2 3.0% 2 1.5% 0.86 
Other 17 26% 33 25% 0.95 
Readmit 4/43 9.3% 7/133 5.3% 0.56 
MI, Myocardial infarction; TIA, transient ischemic attack. 
Other includes atrial fibrillation or other arrhythmia, ngina, atelectasis, confusion, minor cord paresis, headache, 
ulcer, or UTI. 
Readmit s within 30 days; the denominator is given to reflect the number of cases available for follow-up. 
minor hematoma, pain, 
Only 85 (63%) of the 134 cases managed uring 
the Post-CP period were actually placed on the path- 
way. The 49 cases not  managed by this protocol 
included 37 cases (76%) that were ineligible for the 
pathway and 12 cases (24%) that were eligible but 
were not  placed on the pathway (Fig. 1). The mean 
LOS for the 85 cases entering the CP track (CP- 
starters) is presented in Table IV. The POD was 
reduced by 43% for the CP-starters (3.4 + 0.3 days) 
compared with the Pre-CP cases (6.0 + 0.5 days; p < 
0.0001, ANOVA).  The patients who actually com- 
pleted their hospitalizations on the pathway (CP- 
finishers) experienced a 53% reduction in POD 
(2.8 + 0.1 days) compared with the Pre-CP patients 
(p < 0.0001, ANOVA). However, this highly signif- 
icant (p < 0.000I )  reduction in LOS of the CP- 
starters, or CP-finishers, compared with the Pre-CP 
cases is not  scientifically valid. The CP-starters and 
CP-finishers are subsets of the Post-CP group and 
therefore must be compared with equivalently 
matched subsets of the Pre-CP group. The proper 
"control" group against which the CP-starters must 
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Table II I .  Length of stay and cost of hospitalization 
Pre-CP Post-CP % change p 
n 67 134 
Total LOS (days) 8.2 _+ 0.7 7.6 +- 0.8 -7% 0.62 
Preoperative 2.2 +_ 0.3 1.8 _+ 0.3 -18% 0.49 
Postoperative 6.0 _+ 0.5 5.7 -+ 0.6 -5% 0.79 
ICU 1.4 _+ 0.1 1.2 _+ 0.1 -14% 0 .15  
Total charge $12,881 _+ $1163 $15,911 _+ $2114 +24% 0.35 
Routine $5007 -+ $408 $6272 +_ $785 +25% 0.29 
OR $2131 +_ $206 $2414 +_ $111 +13% 0.19 
Medication $583 -+ $64 $724 _+ $120 +24% 0.44 
Radiology $1166 -+ $142 $1264 _+ $197 +8% 0.75 
Laboratory $865 + $100 $1342 + $332 +55% 0.33 
Supply $2054 + $253 $2541 + $247 +24% 0.23 
Therapy $341 + $76 $533 + $161 +56% 0.43 
Other $734 + $145 $820 + $310 +12% 0.85 
All figures in the first two columns represent number of days or dollars -+ standard error of  the mean. 
p values are computed by ANOVA. 
be compared should include only the subset of 
Pre-CP patients who would have been eligible to be 
placed on the pathway had it been available at that 
time. 
We therefore analyzed the Pre-CP group (n = 
67) in a similar fashion to the Post-CP group; 20 of 
the 67 patients (30%) would not have been eligible 
for the CP, including nine patients admitted for 
combined cardiac surgery, six patients transferred 
from other hospitals, three patients transferred from 
the medical service of this hospital, and two cases 
performed emergently. The remaining 47 cases, 
therefore, constitute the true control group for com- 
parison with the CP patients (Fig. 1). In fact, when 
we compared this appropriate Pre-CP control group 
with the CP patients, we identified no significant 
difference in LOS between the two patient popula- 
tions, although a small decrease in LOS, and espe- 
cially POD, was identified in the CP-starters (Table 
V). The reductions in LOS, POD, and ICU LOS 
were greater in the CP-finishers than in the control 
group (Table V). Although statistical analysis would 
have identified significant reductions in LOS among 
the CP-finishers when compared with the control 
group, such a comparison would not be scientifically 
valid because one cannot assume that all control 
patients would have remained on the CP. As noted, 
only 74 of the Post-CP cases who were placed on the 
pathway (87%) remained on it. Finally, we were not 
able to demonstrate a reduction in charges after im- 
plementation of the CP (Table V). 
DISCUSSION 
Critical pathways are increasingly being used to 
guide postoperative care and thereby reduce the cost 
of hospitalization (COH). 4 However, although CPs 
may be effective in guiding patient management by 
alerting house officers and staffto the expected post- 
operative course of an ideal patient, setting CP 
guidelines on the basis of financial criteria alone may 
set unachievable goals for many patients. Clearly, 
analysis of the safety and efficacy of a CP must in- 
clude properly selected and controlled ata as well as 
appropriately performed statistical comparisons. 
The goal of the CP in this study was a 3 day 
postoperative stay. Although our current goal is dis- 
charge on postoperative day 1 or 2, this CP target 
was selected because it was a relatively short POD 
and acceptable at the time of CP formulation in late 
1993. Furthermore, 1 day of postoperative ICU care 
was presumed because adedicated vascular ward was 
not available and a short stay in the recovery room, 6 
billed on an hourly basis, would not be economically 
advantageous in our institution. This initial CEA CP 
was created to be able to work within our institution 
rather than radically change institutional procedures, 
thus testing the effect of the CP mechanism without 
additional confounding factors. The current study 
confirmed that our CEA CP mechanism is safe, be- 
cause patients managed uring the CP era experi- 
enced similar rates of morbidity, mortality, and hos- 
pital readmission when compared with those patients 
managed before CP institution. 
Valid analyses must match equivalent groups. In 
this study, we analyzed cases from equivalent time 
periods (Table III) and equivalently selected cases, 
namely, Post-CP cases that started the CP to the 
Pre-CP cases that would have started the CP had it 
existed at that time (Table V). Within this context we 
demonstrated a small, though statistically insignifi- 
cant, reduction in POD and an increase in total 
COH after CP institution. Although the cases that 
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134 Post-CP cases 
85 CP-starters 
74 CP-finishers 11 fell off CP 
I 
4 (36%) had CNS changes, not including stroke 
3 (27%) had cardiac events (1 requiring cardiac surgery) 
2 (18%) had hematomas requiring operative intervention 
2 (18%) had strokes 
49 not on CP 
37 ineligible 12 eligible 
21 (57%) electively admitted for a combined cardiac procedure 
1 (3%) electively admitted for a combined ent procedure 
5 (13%) transferred from another hospital (often cardiac dx) 
8 (22%) transferred from the inpatient medical service 
2 (5%) were emergent CEA's 
11 were unclear from the chart (6/11 discharged in 3 days) 
1 was emergently performed after the angiogram 
67 Pre-CP cases 
47 control 20 not eligible 
Fig. 1. Analysis of cases with regard to CP track entry. 
Table IV. Length of stay in the Post-CP group that started CP (n = 85) 
Result CP-starters % change CP-finishers % change Fell off CP 
n 85 74 11 
Total LOS 4.3 -+ 0.3 -48% 3.6 _+ 0.2 -56% 8.8 _+ 1.9 
Preoperative 0.9 ± 0.2 -59% 0.9 _+ 0.2 -59% 0.9 _+ 0.3 
Postoperative 3.4 ± 0.3 -43% 2.8 _+ 0.1 -53% 7.9 ± 2.0 
ICU 1.1 + 0.04 -21% 1.0 ± 0.01 29% 1.5 ± 0.3 
All figures represent number of  days ± standard error of  the mean. 
% change represents he preceding column compared to the Pre-CP group (Table III). 
Mean time until incidence of  falling offthe pathway was 28.6 ± 7.1 hours (range, 0 to 72 hours, n = 11). 
Mean COH of the group that fell offthe pathway was $17,189 ± $4188. 
completed the CP had a 53% reduction in POD 
compared with all Pre-CP cases, we believe that this 
observation is not statistically valid; rather, the reduc- 
tion was only 19% when an appropriate control 
group was used (Table V). Similarly, the 33% reduc- 
tion in POD for those patients that completed the 
CP was statistically significant in comparison with the 
"control" group (Table V). However, the "control" 
group is matched to the CP-starters and thus com- 
parison with the CP-finishers is not statistically valid. 
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Table V. Length of stay and cost of hospitalization for control and CP groups 
control CP-starters % change p CP-finishers % change p 
n 47 85 74 
Total LOS 5.2 _+ 0.4 4.3 -+ 0.3 -17% 0.17 3.6 -+ 0.2 -31% .007* 
Preoperative 1.0 ± 0.04 0.9 +- 0.2 -10% 0.90 0.9 -+ 0.2 -10% .89 
Postoperative 4.2 +- 0.4 3.4 -+ 0.3 - i9% 0.17 2.8 -+ 0.1 -33% .004* 
ICU 1.2 ± 0.1 1.1 -+ 0.04 -8% 0.15 1.0 _+ 0.01 -17% .033* 
Total charge $9508 ± $724 $9701 -+ $651 0.97 $8572 ± $246 0.57 
Routine $3718 ± $250 $3750 ± $291 0.99 $3177 ± $124 0.35 
OR $1664 ± $125 $1897 ± $59 0.08 $1806 ± $40 0.42 
Medication $492 _+ $66 $448 ± $48 0.79 $373 ± $12 0.21 
Radiology $884 _+ $133 $743 ± $81 0.59 $691 ± $78 0.40 
Laboratory $629 _+ $79 $624 ± $96 0.99 $492 ± $24 0.51 
Supply $1498 _+ $137 $1746 ± $93 0.28 $1684 ± $92 0.50 
Therapy $131 +_ $34 $126 -+ $57 0.99 $37 ± $4 0.36 
Other $491 _+ $124 $367 ± $50 0.42 $312 ± $18 0.18 
All figures represent umber of days or dollars ± standard error of the mean. 
LOS data for the CP-starters and CP-finishers are from Table IV. 
p value represents he value of the Scheff6 post-hoe test for the group vs control; the Fisher PLSD and Bonferroni/Dunn post-hoe tests 
give similar esults (data not shown). 
*Significant p value. 
Our small reductions in LOS and COH subse- 
quent to CP institution are less than reported in 
other analyses. For example, Calligaro et al. 4 demon- 
strated a 67% reduction in LOS for their CEA pa- 
tients after institution of a CP. That study, however, 
compared patients placed on a CP with a control 
group of all patients who underwent CEA before 
introduction of  the CP. As our work illustrates, this 
method of comparison is not scientifically valid be- 
cause it arbitrarily eliminates all Post-CP cases not 
managed by the CP, and more importantly, because 
it includes Pre-CP cases that would not be eligible 
for a CP. 
There are other differences between the current 
report and other studies examining CPs. For exam- 
ple, most previous tudies that den~oonstrated a bene- 
ficial impact of CPs lack a control group. 7-12 Second, 
although not our current practice, an arteriogram 
was allowed in the operative admission. Ordinarily, 
this adds an extra day to the preoperative LOS that is 
not present in other studies. ~s We continue to obtain 
preoperative outpatient arteriograms in most cases, 
however. Thirdly, all of our Post-CP cases were sent 
to the ICU. Although in some institutions reduc- 
tions in POD and COH have been achieved by 
reducing ICU use, s,l°,ll in our institution the hourly 
rate for recovery room observation has been an eco- 
nomic obstacle to achieving this goal. Fourth, all of 
our cases were performed with the patient under 
general anesthesia, which may prolong recovery 
t ime.  1°,13,14 Fifth, our postoperative l ngth of stay 
goal was set high (3 days) in this initial CEA CP, and 
it has subsequently been revised. Lastly, itis possible 
that our institution was operating fairly efficiently 
before CP implementation, and thus decreases in 
LOS and costs would be difficult to achieve. This is 
suggested by our COH being only half the costs of 
other similar studies ($17,721 in Calligaro et al.4) 
and the failure of our costs to rise ~Ath the rate of 
medical inflation. This is especially significant be- 
cause our financial outliers were not eliminated from 
our statistical analysis) s Alternatively, these observa- 
tions may reflect differences between tertiary care 
university hospitals and community hospitals. 4,12 
There were a greater number of patients who 
underwent operation in our Post-CP group who 
were asymptomatic in comparison with the Pre-CP 
group. This increase was temporally related to the 
preliminary report of the Asymptomatic Carotid Ath- 
erosclerosis Study) 6 Therefore, it is likely that this 
reflected an increase in the referral of asymptomatic 
patients and not a decrease in patient acuity. In fact, 
the Post-CP patients were older than the Pre-CP 
cases. In addition, the incidence of coronary artery 
disease was imilar between the two groups, al- 
though congestive heart failure and COPD were 
seen less frequently in the Post-CP group. 
CONCLUSION 
Our data indicate that the methods used are cru- 
cial in analyzing the impact of cost-reducing strate- 
gies. Specifically, when evaluating the potential ben- 
efits of a CP, one must carefully select an appropriate 
control group. As noted in this analysis, including 
patients who would not be candidates for a CP in the 
control group clearly overstated the benefit of the 
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CP. Fur thermore ,  because all patients may not  be 
eligible for management  by a CP, or may "fall off" 
the pathway as a result o f  compl icat ions or other  
confound ing  factors, accordingly,  f inancial reim- 
bursement  levels based on  critical pathways should 
be flexible. 
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